BETHLEHEM, Pa., Nov. 17, 2011 /PRNewswire/ -- MedClean Technologies (OTC Bulletin Board: MCLN), the leading provider of onsite technology for the treatment and disposal of medical waste and the destruction of confidential documents and related media, today announced it has signed an agreement with ARAMARK for the purchase of a MedClean 4300 fixed-based sterilization system.
The agreement includes the purchase and installation of the equipment at Community Medical Center in Scranton, PA, plus additional recurring consumable orders for the life of the equipment, estimated for a period of approximately 10 years. ARAMARK will provide comprehensive hospital management services that include implementing expense reduction programs that incorporate the use of MedClean's sterilization technology. The installation of the equipment is expected to commence and be completed in the fourth quarter of 2011.
"This agreement represents a case study in cooperation amongst ARAMARK, Community Medical Center, and MedClean to achieve beneficial results in the form of expense reductions utilizing MedClean's fixed-base technology, ARAMARK's industry leading hospital service capabilities, and Community Medical Center's own personnel," commented David Laky, President and CEO of MedClean Technologies, Inc. "We appreciate the fact the we were able to work in partnership with ARAMARK on this project and we will strive to continue to offer beneficial programs to ARAMARK and their valued customers."
"The deployment of the MedClean 4300 system will enable ARAMARK to reduce its operating costs while continuing to serve the Community Medical Center," continued Mr. Laky. "Cost effective services and solutions are critical to all organizations in the current economy."
ARAMARK is a leader in professional services, providing award-winning food services, facilities management, and uniform and career apparel to health care institutions, universities and school districts, stadiums and arenas, and businesses around the world. The company is recognized as one of the "World's Most Ethical Companies" by the Ethisphere Institute, as the industry leader in FORTUNE magazine's "World's Most Admired Companies," and as one of America's Largest Private Companies by both FORTUNE and Forbes magazines. ARAMARK seeks to responsibly address issues that matter to its clients, customers, employees and communities by focusing on employee advocacy, environmental stewardship, health and wellness, and community involvement. Headquartered in Philadelphia, ARAMARK has approximately 255,000 employees serving clients in 22 countries. Learn more at www.twitter.com/aramarknews.
About MedClean Technologies, Inc.
MedClean Technologies, Inc. is a provider of innovative technology and services for the onsite treatment and disposal of regulated medical waste. MedClean's flagship MedClean® Series systems are fully integrated, turnkey technology solutions that enable hospitals and other healthcare providers to safely, efficiently, and cost-effectively convert bio-hazardous regulated medical waste into sterile, unrecognizable material suitable for disposal as municipal solid waste. MedClean was founded in 1997 with corporate headquarters, research and development and distribution facilities located in Bethel, Connecticut. Further, information on MedClean can be found at www.medcleantechnologies.com and in filings with the Securities and Exchange Commission found at www.sec.gov.
Statements about our future expectations are "forward-looking statements" within the meaning of applicable Federal Securities Laws, and are not guarantees of future performance. When used herein, the words "may," "will," "should," "anticipate," "believe," "appear," "intend," "plan," "expect," "estimate," "approximate," "potential" and similar expressions are intended to identify such forward-looking statements. These statements involve risks and uncertainties inherent in our business, including those set forth in our most recent Annual Report on Form 10-K for the year ended December 31, 2009, filed with the SEC on March 3, 2010, and other filings with the SEC, and are subject to change at any time. Our actual results could differ materially from these forward-looking statements. We undertake no obligation to update publicly any forward-looking statement.
SOURCE MedClean Technologies, Inc.